A reviewer on Amazon asked me if I knew anything about new Alzheimer’s treatments in development, which led to this! I don’t think Amazon is letting through links in reviews or comments anymore, so this is definitely the best way to get it.
Here’s a great, brand-new scholarly article about the current state of stem cell therapies being developed for Alzheimer’s (personally, as y’all probably know by now, I think that’s where the cure will come from.)
The best part is that the full article is available free on Pubmed Central. Here’s the link for that:
Another thing I know of is some new work with identifying more information about a gene that carries risk for developing Alzheimer’s. The stem cell link is that induced pluripotent stem cells are being used in the process (which is the best use for them at the present time, I think. IMHO, they’re so not ready for clinical application.)
So take a look at those (especially the first one), and I’ll have Day Six of the UC-Davis conference coming up very soon. 🙂
I survived the disease, and I now have the only remission on record. But a remission is not a cure. The stem cell drug I need for a real cure is now rapidly moving towards approval in the rest of the world, but in the USA, it—and all other cellular therapies-- are still stuck behind prejudice, ignorance, and lack of funding. Hundreds of millions of desperate patients with incurable diseases need these drugs.
That’s why I’ve gone on to fight for greater public education on stem cell drugs, knowing that our laws must be changed so that all of us can get access to the best treatments instead of our health and our lives being held hostage by special interests.
I’m now a patient advocate whose work on stem cells and patients’ rights has been published in outlets such as the Oregonian. I am a manager at popular science and financial blog www.stemcellinvestor.com and a frequent speaker at many venues across the spectrum, including churches, scientific conferences, and atheist groups, and everything in between. I’m also an advocate for Right to Try laws that would allow access to experimental medication for terminal patients at the state level. Read the entire story in my upcoming book, And the Blind Shall See: A Skeptic Patient Surprised by Faith, Science, Family, and Miracle Cures.
Latest posts by Cathy Danielson (see all)
- A new story about shareholder determination! - January 21, 2016
- The Latest Thoughts on Why Ocata is Being Bought out by Astellas - November 29, 2015
- The Missing Word: Why we don’t have stem cell cures. - November 23, 2015